Dr. Robert Yao-Wen Lin, MD

Dr. Lin practices at Midtown Sinus Imaging in Glendale, New York.

Dr. Lin's NPI, 1932244274, was assigned on February 21, 2007. Dr. Lin graduated from SUNY Downstate Health Sciences University in 1976. Dr. Lin holds New York license 131322-1.

Dr. Lin's primary practice is Midtown Sinus Imaging, at 79-49 Myrtle Ave, Glendale, NY 11385 in Queens County. The practice phone is (212) 686-6321.

Dr. Lin's primary practice is Midtown Sinus Imaging in Glendale, New York. The medical group on file is NY Allergy & Sinus Centers. Dmand AI also links Dr. Lin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Lin is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Lin's licenses on file in 4 states: New York, New Jersey, California and Maryland.

Dmand AI lists chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Lin treats.

CMS data shows 147 Medicare services from Dr. Lin across 4 procedure codes in 2024, for 66 Medicare patients. Medicare paid $7,782 for them. Every service was in an office.

CMS counts 66 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 37, with 58% women.

In 2024, Dr. Lin wrote 1,339 Medicare Part D claims for 162 patients. 66% of them were for generic drugs. CMS names the drug for 1,208 of them, across 22 drugs with 11 or more claims each, at $877,890 in total drug cost. In 2023, CMS named 1,157 claims across 26 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 91 papers to Dr. Lin, published from 2008 to 2022. 2012 was the busiest year, with 2. The most frequent topics are Asthma, Anaphylaxis and Hypersensitivity. Dr. Lin has published most often in Ann Allergy Asthma Immunol. Dr. Lin's most frequent co-authors are Howard Menikoff, MD, Richard J. Knight, MD and Elina Jerschow, MD.

Dmand AI links Dr. Lin to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Eczema and Dermatitis, Atopic. Open Payments lists research payments to Dr. Lin that name 1 trial.

CMS Open Payments shows 1,095 general payments to Dr. Lin from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $4,543. It also lists 11 research payments totaling $5,730 from 2021 to 2022, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from SUNY Downstate Health Sciences University in 1976. Dr. Lin is a member of AAAAI.

Dr. Lin is in network with 15 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.